Showing results (131-140 of 166) with videos related to

Sort By:
Pageof 17
Annals of Surgical Oncology|July 28, 2026
Successful Redo Right Hepatic Vein Reconstruction for Recurrent Colorectal Liver Metastases After Triple Hepatic Vein Resection: Implications of Late-Onset Venous StenosisYui Sawa, Yoshihiro Ono, Gaku Shimane, et al.
BJS Open|April 9, 2025
Western and Eastern experience in treating perihilar cholangiocarcinoma: retrospective bi-centre studyHannes Jansson, Atsushi Oba, Aya Maekawa, et al.
Annals of Surgical Oncology|October 18, 2025
Surgical Technique and Feasibility of Pancreaticoduodenectomy after Surgery for Perihilar CholangiocarcinomaKota Sugiura, Atsushi Oba, Mamiko Miyashita, et al.
International Journal of Cancer|July 13, 2002
Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC-3Kazuhiro Suzuki, Hidekazu Koike, Hiroshi Matsui, et al.
Annals of Surgical Oncology|November 11, 2023
Technical Strategy for Pancreatic Body Cancers: A Raison d'etre of Distal Pancreatectomy with Portal ResectionAya Maekawa, Atsushi Oba, Yosuke Inoue, et al.
Annals of Surgery|January 26, 2022
Serum DUPAN-2 could be an Alternative Biological Marker for CA19-9 Nonsecretors with Pancreatic CancerKojiro Omiya, Atsushi Oba, Yosuke Inoue, et al.
Annals of Surgical Oncology|November 26, 2025
Robotic Pancreatectomy as an Adjunct to Radical Gastrectomy for Advanced Gastric Cancer: Surgical and Clinical ImplicationsAtsushi Oba, Gaku Shimane, Rie Makuuchi, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 14, 2025
Assessing surgical resection in recurrent biliary tract cancer: International two-centre experienceYoshiyuki Shibata, Hannes Jansson, Kosuke Kobayashi, et al.
Annals of Surgery|August 29, 2025
Assessment of Residual or Resected Disappearing Liver Metastases After Chemotherapy: The AROD StudyKosuke Kobayashi, Atsushi Oba, Sho Kiritani, et al.
Frontiers in Immunology|April 19, 2024
Immunoglobulin-like transcript 2 as an impaired anti-tumor cytotoxicity marker of natural killer cells in patients with hepatocellular carcinomaToshihiro Sakata, Sachiyo Yoshio, Taiji Yamazoe, et al.
Pageof 17